Skip to main content
KimeraCHEMS
Display
  • C
  • N
  • O

Calculated reference model · not an experimental or batch-certified structure. All 11 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • The source record leaves some stereochemistry unspecified. This calculated conformer does not establish a unique stereoisomer.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C6H10N2O3
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer
Made
2026-02-04
Reports
3 on file
Everything shipping from this page today came off this batch. The code is printed on your label, and one certificate covers the whole batch.

Oxiracetam

Nootropics

Published formats

  • Powder 50g
  • Dry-Fill Capsule 120ct/400mg/48g
What is the difference between these?
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Technical Specifications

Batch COA Database ↗
CAS Registry Number62613-82-5
Molecular FormulaC₆H₁₀N₂O₃
Molecular Weight158.16
IUPAC Designation(RS)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide
Physical FormFine crystalline white or off-white powder
Storage RequirementsRefer to product documentation
Other NamesISF 2522, CGP 21690E, ISF-2522, CT-848, CGP-21690E, GNF-PF-1005
Capsule Concentration400mg x 120ct
Bulk Powder Quantity50g

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

Oxiracetam Research Standard

Oxiracetam (4-hydroxy-2-oxo-1-pyrrolidineacetamide) is a synthetic derivative of the piracetam family, characterized by the addition of a hydroxyl group to the pyrrolidone nucleus. This modification increases its potency compared to parent compounds, making it a staple in neuropharmacological research. Oxiracetam is primarily utilized as a specialized laboratory tool for investigating cognitive signaling pathways, specifically those related to cholinergic and glutamatergic neurotransmission, as well as cerebral energy metabolism in in vitro neural tissue models.

Physical & Handling Properties

Property Specification
Physical Appearance Fine crystalline white or off-white powder

Mechanism of Action & Research Context

Oxiracetam is studied for its ability to modulate key neurotransmitter systems and metabolic processes within the brain, particularly in contexts involving high-density neural information processing.

  • Cholinergic and Glutamatergic Modulation: Research indicates that oxiracetam may influence the release of acetylcholine and the modulation of glutamate receptors, which are essential for synaptic plasticity and the formation of long-term potentiation (LTP).

  • Metabolic Enhancement: The compound is evaluated for its capacity to optimize oxygen and glucose utilization pathways in neural tissues, potentially stabilizing ATP production in cell-based energy models.

  • Signaling Efficacy: By targeting these pathways, oxiracetam is used to measure the rate at which neural networks adapt and reorganize, providing a quantitative model for studying memory and learning efficiency.

Research Applications

Oxiracetam is a versatile reference compound utilized for exploring cognitive pathways in controlled laboratory settings.

Primary fields of in vitro laboratory investigation include:

  • Neurotransmitter Activity Mapping: Measuring glutamate-related signaling dynamics and cholinergic transmission in cultured hippocampal tissue.

  • Cellular Bioenergetics: Testing the compound’s influence on mitochondrial glucose uptake and oxygen consumption during metabolic stress.

  • Synaptic Plasticity: Observing the speed and fidelity of information storage/retrieval in controlled neuronal network models.

  • Cognitive Pharmacology: Serving as a benchmark for comparing the potency and activity profile of newer synthetic racetam derivatives.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

References

  • Valzelli L, et al. (1980) "Oxiracetam: a psychotropic drug with learning-enhancing properties." Pharmacological Research Communications. 12(6): 579–583.

  • Malykh AG, Sadaie MR. (2010) "Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders." Drugs. 70(3): 287–312.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Currently shipping from batch KC-OXR-02.

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.